Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1971 2
1972 1
1973 2
1974 1
1975 5
1976 3
1977 6
1978 1
1979 7
1980 9
1981 17
1982 11
1983 19
1984 9
1985 18
1986 15
1987 18
1988 21
1989 25
1990 23
1991 24
1992 37
1993 37
1994 53
1995 50
1996 27
1997 63
1998 40
1999 41
2000 35
2001 56
2002 49
2003 92
2004 91
2005 86
2006 79
2007 95
2008 118
2009 105
2010 108
2011 134
2012 162
2013 146
2014 157
2015 148
2016 157
2017 157
2018 153
2019 171
2020 183
2021 139
2022 135
2023 108
2024 67

Text availability

Article attribute

Article type

Publication date

Search Results

3,169 results

Results by year

Filters applied: . Clear all
Page 1
Advanced Prostate Cancer: Treatment Advances and Future Directions.
Swami U, McFarland TR, Nussenzveig R, Agarwal N. Swami U, et al. Trends Cancer. 2020 Aug;6(8):702-715. doi: 10.1016/j.trecan.2020.04.010. Epub 2020 Jun 10. Trends Cancer. 2020. PMID: 32534790 Review.
Prostate cancer affects one in every nine men in the USA and is the second leading cause of cancer-related death. The treatment landscape of advanced prostate cancer is changing rapidly. Multiple agents including abiraterone, enzalutamide …
Prostate cancer affects one in every nine men in the USA and is the second leading cause of cancer-related death. The t …
Complications of advanced prostate cancer.
Smith JA Jr, Soloway MS, Young MJ. Smith JA Jr, et al. Urology. 1999 Dec;54(6A Suppl):8-14. doi: 10.1016/s0090-4295(99)00448-3. Urology. 1999. PMID: 10606278 Review.
Currently, there is a lot of focus directed toward discovering treatments for patients with hormone refractory prostate cancer (HRPC) that will lead to increased survival. Until such treatments emerge, palliation is important to ensure patients the highest possible …
Currently, there is a lot of focus directed toward discovering treatments for patients with hormone refractory prostate cancer …
Diagnosis of advanced prostate cancer at the community level in Rwanda.
Nzeyimana I, Nyirimodoka A, Ngendahayo E, Bonane A, Muhawenimana E, Umurangwa F, Gasana A, Sibomana AM, Teplitsky S, Rusatira C, Rickard J, Hategekimana T, Rwamasirabo E. Nzeyimana I, et al. Int Urol Nephrol. 2021 Oct;53(10):1977-1985. doi: 10.1007/s11255-021-02921-8. Epub 2021 Jun 30. Int Urol Nephrol. 2021. PMID: 34191229
If not recognized early, patients with advanced prostate cancer can experience debilitating complications which can otherwise be prevented by early androgen deprivation therapy. ...CONCLUSION: The results show that there is a significant correlation be …
If not recognized early, patients with advanced prostate cancer can experience debilitating complications which …
Contemporary management of advanced prostate cancer: an evolving landscape.
Khanna A, O'Connor LP, Murthy PB, Bryk DJ, Fascelli M, Ericson K, Yerram NK, Haywood SC, Abouassaly R. Khanna A, et al. Clin Adv Hematol Oncol. 2021 Feb;19(2):108-118. Clin Adv Hematol Oncol. 2021. PMID: 33596192 Review.
Recent population-based studies suggest that the incidence of advanced and metastatic prostate cancer may be increasing. Concurrently with this apparent stage migration toward advanced disease, several major developments have occurred in the treatment …
Recent population-based studies suggest that the incidence of advanced and metastatic prostate cancer may be increasing …
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer.
Zhang X. Zhang X. Cancer Commun (Lond). 2019 Nov 21;39(1):76. doi: 10.1186/s40880-019-0425-1. Cancer Commun (Lond). 2019. PMID: 31753020 Free PMC article. Review.
Here, we explained the mechanism of interactions between prostate cancer cells and metastasis-associated cells within the bone microenvironment and further discussed the recent advances in targeted therapy of prostate cancer bone metastasis. Thi …
Here, we explained the mechanism of interactions between prostate cancer cells and metastasis-associated cells within the bone …
Managing the local complications of locally advanced prostate cancer.
Anast JW, Andriole GL, Grubb RL 2nd. Anast JW, et al. Curr Urol Rep. 2007 May;8(3):211-6. doi: 10.1007/s11934-007-0008-6. Curr Urol Rep. 2007. PMID: 17459270 Review.
Complications of locally advanced prostate cancer are often overlooked in the overall treatment of prostate cancer, can have significant morbidity, and can provide a challenge for the treating urologist. Despite advances in early d …
Complications of locally advanced prostate cancer are often overlooked in the overall treatment of prostate …
Treatment of bone complications in advanced prostate cancer: rationale for bisphosphonate use and results of a phase III trial with zoledronic acid.
Saad F. Saad F. Semin Oncol. 2002 Dec;29(6 Suppl 21):19-27. doi: 10.1053/sonc.2002.37418. Semin Oncol. 2002. PMID: 12584691 Review.
Prostate cancer often metastasizes to bone during disease progression. ...These results suggest that zoledronic acid may become an important advancement in the care of patients with prostate cancer metastatic to bone. ...
Prostate cancer often metastasizes to bone during disease progression. ...These results suggest that zoledronic acid may becom …
Local salvage of radiorecurrent prostate cancer.
Henderson RH, Bryant C, Nichols RC Jr, Mendenhall WM, Mendenhall NP. Henderson RH, et al. Prostate. 2023 Aug;83(11):1001-1010. doi: 10.1002/pros.24551. Epub 2023 May 7. Prostate. 2023. PMID: 37150849 Review.
BACKGROUND: Locally recurrent prostate cancer following primary external beam radiotherapy without distant metastasis is a challenging problem, with no current consensus on the optimal management of these patients. Traditional whole-gland salvage treatments offered …
BACKGROUND: Locally recurrent prostate cancer following primary external beam radiotherapy without distant metastasis is a cha …
Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.
Saika T, Miura N, Fukumoto T, Yanagihara Y, Miyauchi Y, Kikugawa T. Saika T, et al. Int J Urol. 2018 Jan;25(1):30-35. doi: 10.1111/iju.13441. Epub 2017 Sep 13. Int J Urol. 2018. PMID: 28901630 Review.
Locally advanced prostate cancer is regarded as a very high-risk disease with a poor prognosis. Although there is no definitive consensus on the definition of locally advanced prostate cancer, radical prostatectomy for locally advanced …
Locally advanced prostate cancer is regarded as a very high-risk disease with a poor prognosis. Although there is no de …
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation.
Merkens L, Sailer V, Lessel D, Janzen E, Greimeier S, Kirfel J, Perner S, Pantel K, Werner S, von Amsberg G. Merkens L, et al. J Exp Clin Cancer Res. 2022 Feb 2;41(1):46. doi: 10.1186/s13046-022-02255-y. J Exp Clin Cancer Res. 2022. PMID: 35109899 Free PMC article. Review.
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on increased androgen receptor (AR) signaling. ...To date, various mechanisms of resistance have been identified including the development of AR-independent aggressive variant pro …
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on increased androgen receptor (AR) signal …
3,169 results